The in vitro mammalian chromosome aberration test

Methods in Molecular Biology

Volumn 817, Issue , 2012, Pages 69-91

  Clare, Gill ^a  

^a NONE   (United Kingdom)

Author keywords

Accurate test result; Cyclophosphamide; Cytogenetics; Cytotoxicity; Established cell lines; Human lymphocytes; In vitro mammalian chromosome aberration test; Regulatory assay; S 9 mix; Structural chromosome aberrations; Whole blood cultures

Indexed keywords

MAMMALIA;

EID: 84855998622     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-421-6_5     Document Type: Article

References (34)

1. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (2000) Guidance on a Strategy for Testing of Chemicals for Mutagenicity. Introduction Department of Health, UK pp 5-7.
2. European Agency for the Evaluation of Medicinal Products (1995) ICH Topic S 2 A. Genotoxicity: Guidance on Specific Aspects of Genotoxicity Tests for Pharmaceuticals. ICH Harmonised Tripartite Guideline.
3. OECD (1997) 'Genetic Toxicology: In vitro mammalian Cytogenetic Test'. In OECD Guidelines for the testing of chemicals. OECD Paris, Test Guideline 473.
4. US EPA (1998) Health Effects Test Guideline OPPTS 870.5375 In Vitro Mammalian Chromosome Aberration Test. EPA 712-C-98-223.
5. EC Commission Directive 2000/32/EC (2000) Annex 4A B.10. Mutagenicity-In Vitro Mammalian Chromosome Aberration Test.
6. Tweats D.J., Scott A.D., Westmorland C. and Carmichael P.L. (2007) Determination of genetic toxicity and potential carcinogenicity in vitro-challenges post the Seventh Amendment to the European Cosmetics Directive. Mutagenesis 22, 5-13. (Pubitemid 46058637)
7. Kirkland D., Pfuhler S., Tweats D. et al (2007) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM workshop. Mutat. Res. 628, 31-55.
8. Nowell, P.C. (1960) Phytohaemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. Cancer Research, 20, 462.
9. Evans H.J. and O'Riordan M.L. (1975) Human peripheral blood lymphocytes for the analysis of chromosome aberrations in muta-gen tests. Mutation Research, 31, 135.
10. Evans H.J. (1984) Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. In Handbook of Mutagenicity Test Procedures (Kilbey B.J. et al eds) Elsevier Science Publishers, pp 407-427.
11. Scott D., Dean B.J, Danford N.D. and Kirkland D.J. (1990) Metaphase chromosome aberration assays in vitro. In Basic Mutagenicity Tests: UKEMS recommended procedures. Report. Part 1 revised. (Kirkland D.J. ed.) Cambridge University Press, Cambridge, UK. pp 62-84.
12. Freshney R.I. (2006). Basic Principles of Cell Culture. In Culture of Cells for Tissue Engineering. (Vunjak-Novakovic G., Freshney R.I. eds.) John Wiley & Sons, Inc., pp 3-22.
13. Corby N (2000) http://www.abdn.ac.uk/safety/uploads/files/blood.doc.
14. Advisory Committee on Dangerous Pathogens Protection against blood borne infections in the workplace: HIV and hepatitis. The Stationery Office, 1996, ISBN 0113219539.
15. Hone P., Edwards A., Lloyd D., Moquet J. (2005) The yield of radiation-induced chromosomal aberrations in first division human lymphocytes depends on the culture time. Int J Radiat. Biol. 81, 523-529. (Pubitemid 41687202)
16. Goto K., Maeda S., Kano Y. and Sugiyama T. (1978) Factors involved in differential Giemsa-staining of sister chromatids. Chromosoma (Berl.) 66, 351-359. (Pubitemid 8338046)
17. Marshall R., Tricta F., Galanello R. et al. (2003) Chromosomal aberration frequencies in patients with thalassaemia major undergoing therapy with deferiprone and deferoxamine in a comparative crossover study. Mutagenesis 18, 457-463. (Pubitemid 37098977)
18. Edwards A.A. et al. (2005) Review of translo-cations detected by FISH for retrospective biological dosimetry applications. Radiation Protection Dosimetry 113, 396-402. (Pubitemid 40873450)
19. An International System for Cytogenetic Nomenclature (1995). Report of the Standing Committee on Human Cytogenetic Nomenclature S. (Hardnen D.G. and Klinger H.P. eds.) Karger A.G., Basel (Switzerland).
20. Richardson C., Williams D.A., Allen J.A., Amphlett G., Chanter, D.O. and Phillips B. (1989) Analysis of data from in vitro cytogenetic assays. In Statistical Evaluation of Mutagenicity Test Data: UKEMS sub-committee on guidelines for mutagenicity testing. Report. Part 111. (Kirkland D.J. ed.) Cambridge University Press, Cambridge, UK. pp 141-154.
21. Hilliard C.A., Armstrong M.J., Bradt C.I., Hill R.B. Greenwood S.K. and Galloway S.M. (1998) Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons. Environ and Mol. Mutagenesis 31, 316-326 (Pubitemid 28308461)
22. Doak S.H., Jenkins G.J.S., Johnson G.E. et al (2007) Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 67, 3904-3911. (Pubitemid 46762179)
23. Ishidate M.Jr., Harnois M.C. and Sofuni T. (1988) A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell culture. Mutat. Res. 195, 151-213. (Pubitemid 18066068)
24. Ishidate M Jr (1987) Chromosomal aberration test in vitro (Ed) L.I.C. Inc. Tokyo.
25. Galloway S M, Armstrong M J, Reuben C, Colman S, Brown B, Cannon C, Bloom A D, Nakamura F, Ahmed N, Duk S, Rimpo J, Margolin B H, Resnick M A, Anderson B and Zeiger E (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ Mol Mutagenesis 10, Suppl 10, 1-175. (Pubitemid 18039247)
26. Galloway S M, Aardema M J, Ishidate M, Ivett J L, Kirkland D J, Morita T, Mosesso P, Sofuni T (1994) Report from working group on in vitro tests for chromosomal aberrations. In: Sheila M. Galloway (Ed), Report of the International Workshop on Standardisation of Genotoxicity Test Procedures. Mutation Research 312, 241-261. (Pubitemid 24187387)
27. European Agency for the Evaluation of Medicinal Products (2006) ICH Topic S 2 R1: Final concept paper: Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use.
28. Scott D, Galloway S M, Marshall R R, Ishidate M, Brusick D, Ashby J and Myhr B C (1991) Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. Mutation Research 257, 147-204.
29. Brusick D (1986) Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environ Mutagenesis 8, 879-886. (Pubitemid 17188042)
30. Ku W.W., Bigger A., Brambilla G. et al (2007) Strategy for genotoxicity testing-metabolic considerations. Mutat. Res. 627, 59-77. (Pubitemid 46091767)
31. Knasmuller S., Parzefall W., Sanyal R. et al (1998) Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat. Res. 402, 185-202. (Pubitemid 28440274)
32. Parry E.M., Parry J.M., Corso C., et al (2002) Detection and characterisation of mechanisms of action of aneugenic chemicals. Mutagenesis 17, 509-521. (Pubitemid 35414779)
33. O'Donovan M.R.O., Johns S. and Wilcox P. (1995a) The effect of PHA stimulation on lymphocyte sub-populations in whole-blood cultures. Mutagenesis 10, 371-374.
34. O'Donovan M.R.O., Freemantle M.R., Hull G. et al (1995b) Extended cultures of human T-lymphocytes: a practical alternative to primary human lymphocytes for use in genotoxicity testing. Mutagenesis 10, 189-201.